- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01972815
Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal Swabs
October 29, 2013 updated by: National Taiwan University Hospital
Nasopharyngeal carcinoma (NPC) is a virus-associated cancer that is rare among Caucasians but occurs at an elevated rate among Southern Asians.
Rates of NPC are particularly high among individuals with a family history of this disease, but no specific genetic factors have been identified that can serve to guide clinical management of this high-risk population to ensure early detection and treatment of this life-threatening condition.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- Nation Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
suspect NPC patients
Description
Inclusion Criteria:
- suspect NPC patients
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
positive agreement among the positives, coefficient of variation
Time Frame: Four years
|
Four years
|
|
positive agreement among the positives, coefficient of variation
Time Frame: four years
|
CV=SD/mean * 100
|
four years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
October 1, 2012
Study Registration Dates
First Submitted
October 24, 2013
First Submitted That Met QC Criteria
October 29, 2013
First Posted (Estimate)
October 30, 2013
Study Record Updates
Last Update Posted (Estimate)
October 30, 2013
Last Update Submitted That Met QC Criteria
October 29, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201205060RIB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suspect NPC Patients
-
National University Hospital, SingaporeOtsuka Pharmaceutical Co., Ltd.Unknown
-
Prince of Songkla UniversityCompletedNormal Population | Glaucoma Patient | Glaucoma Suspect Patient | RNFL Thickness by Location | Macular Thickness by LocationThailand
-
Duke UniversityTerminatedGlaucoma | Glaucoma, SuspectUnited States
-
Manchester University NHS Foundation TrustColumbia University; University of ManchesterCompletedGlaucoma | Glaucoma, SuspectUnited Kingdom
-
Instituto Universitario de Oftalmobiología Aplicada...CompletedOcular Hypertension | Glaucoma | Glaucoma, SuspectSpain
-
VER Excelência em OftalmologiaCompleted
-
Duke UniversityRecruiting
-
Oftalmologia Hospital Sotero del RioUnknown
-
Benha UniversityRecruitingGlaucoma | Intraocular Pressure | Glaucoma, SuspectEgypt